Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Chemotherapy administration to breast cancer patients affects extracellular vesicles thrombogenicity and function.

Aharon A, Sabbah A, Ben-Shaul S, Berkovich H, Loven D, Brenner B, Bar-Sela G.

Oncotarget. 2017 Jun 28;8(38):63265-63280. doi: 10.18632/oncotarget.18792. eCollection 2017 Sep 8.

2.

Macrophage-Induced Lymphangiogenesis and Metastasis following Paclitaxel Chemotherapy Is Regulated by VEGFR3.

Alishekevitz D, Gingis-Velitski S, Kaidar-Person O, Gutter-Kapon L, Scherer SD, Raviv Z, Merquiol E, Ben-Nun Y, Miller V, Rachman-Tzemah C, Timaner M, Mumblat Y, Ilan N, Loven D, Hershkovitz D, Satchi-Fainaro R, Blum G, P Sleeman J, Vlodavsky I, Shaked Y.

Cell Rep. 2016 Oct 25;17(5):1344-1356. doi: 10.1016/j.celrep.2016.09.083.

3.

Tumor-derived microparticles induce bone marrow-derived cell mobilization and tumor homing: a process regulated by osteopontin.

Fremder E, Munster M, Aharon A, Miller V, Gingis-Velitski S, Voloshin T, Alishekevitz D, Bril R, Scherer SJ, Loven D, Brenner B, Shaked Y.

Int J Cancer. 2014 Jul 15;135(2):270-81. doi: 10.1002/ijc.28678. Epub 2014 Jan 13.

4.

Differential therapeutic effects of anti-VEGF-A antibody in different tumor models: implications for choosing appropriate tumor models for drug testing.

Alishekevitz D, Bril R, Loven D, Miller V, Voloshin T, Gingis-Velistki S, Fremder E, Scherer SJ, Shaked Y.

Mol Cancer Ther. 2014 Jan;13(1):202-13. doi: 10.1158/1535-7163.MCT-13-0356. Epub 2013 Oct 22.

5.

Low-dose metronomic chemotherapy: from past experience to new paradigms in the treatment of cancer.

Loven D, Hasnis E, Bertolini F, Shaked Y.

Drug Discov Today. 2013 Feb;18(3-4):193-201. doi: 10.1016/j.drudis.2012.07.015. Epub 2012 Aug 4. Review.

PMID:
22868084
6.

Host response to short-term, single-agent chemotherapy induces matrix metalloproteinase-9 expression and accelerates metastasis in mice.

Gingis-Velitski S, Loven D, Benayoun L, Munster M, Bril R, Voloshin T, Alishekevitz D, Bertolini F, Shaked Y.

Cancer Res. 2011 Nov 15;71(22):6986-96. doi: 10.1158/0008-5472.CAN-11-0629. Epub 2011 Oct 6.

7.

How are we doing? One hospice's patient advocacy program.

Loven D, Rivers M.

Caring. 2010 Aug;29(8):18-21. No abstract available.

PMID:
21067116
8.

Long-term glutamate supplementation failed to protect against peripheral neurotoxicity of paclitaxel.

Loven D, Levavi H, Sabach G, Zart R, Andras M, Fishman A, Karmon Y, Levi T, Dabby R, Gadoth N.

Eur J Cancer Care (Engl). 2009 Jan;18(1):78-83. doi: 10.1111/j.1365-2354.2008.00996.x.

PMID:
19473225
9.

Daily low-dose/continuous capecitabine combined with neo-adjuvant irradiation reduces VEGF and PDGF-BB levels in rectal carcinoma patients.

Loven D, Be'ery E, Yerushalmi R, Koren C, Sulkes A, Lavi I, Shaked Y, Fenig E.

Acta Oncol. 2008;47(1):104-9.

PMID:
17851858
10.
11.

Sister Mary Joseph's nodule as a presenting sign of internal malignancy.

Dodiuk-Gad R, Ziv M, Loven D, Schafer J, Shani-Adir A, Dyachenko P, Rozenman D.

Skinmed. 2006 Sep-Oct;5(5):256-8.

PMID:
16957443
12.

Preoperative chemoradiation in rectal cancer: Retrospective comparison between capecitabine and continuous infusion of 5-fluorouracil.

Yerushalmi R, Idelevich E, Dror Y, Stemmer SM, Figer A, Sulkes A, Brenner B, Loven D, Dreznik Z, Nudelman I, Shani A, Fenig E.

J Surg Oncol. 2006 Jun 1;93(7):529-33.

PMID:
16705722
13.

Non-resectable slow-growing meningiomas treated by hydroxyurea.

Loven D, Hardoff R, Sever ZB, Steinmetz AP, Gornish M, Rappaport ZH, Fenig E, Ram Z, Sulkes A.

J Neurooncol. 2004 Mar-Apr;67(1-2):221-6.

PMID:
15072471
14.

Targeting pulmonary metastases of renal cell carcinoma by inhalation of interleukin-2.

Merimsky O, Gez E, Weitzen R, Nehushtan H, Rubinov R, Hayat H, Peretz T, Ben-Shahar M, Biran H, Katsenelson R, Mermershtein V, Loven D, Karminsky N, Neumann A, Matcejevsky D, Inbar M.

Ann Oncol. 2004 Apr;15(4):610-2.

PMID:
15033668
15.

Comparative genomic hybridization analysis of radiation-associated and sporadic meningiomas.

Rienstein S, Loven D, Israeli O, Ram Z, Rappaport ZH, Barkai G, Goldman B, Aviram-Goldring A, Friedman E.

Cancer Genet Cytogenet. 2001 Dec;131(2):135-40.

PMID:
11750053
16.

Effect of P-glycoprotein expression on outcome in the Ewing family of tumors.

Perri T, Fogel M, Mor S, Horev G, Meller I, Loven D, Issakov J, Kollender Y, Smirnov A, Zaizov R, Cohen IJ.

Pediatr Hematol Oncol. 2001 Jul-Aug;18(5):325-34.

PMID:
11452404
17.

Diffuse brain stem gliomas. Are we improving outcome?

Shuper A, Kornreich L, Loven D, Michowitz S, Schwartz M, Cohen IJ.

Childs Nerv Syst. 1998 Oct;14(10):578-81.

PMID:
9840382
18.

Effect of superoxide dismutase on a rabbit model of chronic allergic asthma.

Assa'ad AH, Ballard ET, Sebastian KD, Loven DP, Boivin GP, Lierl MB.

Ann Allergy Asthma Immunol. 1998 Mar;80(3):215-24.

PMID:
9532968
19.

Antioxidant enzyme activity in murine hematopoietic bone marrow following treatment with interleukin 1 alpha: influence of tumor.

Johnke RM, Abernathy RS, Kovacs CJ, Evans MJ, Biggs LE, Daly BM, Loven DP.

Anticancer Res. 1997 May-Jun;17(3C):2169-74.

PMID:
9216682
20.

[Malignant epidural cord compression].

Loven D, Gørnish M, Fenig GE, Sulkes A, Rappaport Z, Klir I, Rotenberg Z, Gadoth N.

Harefuah. 1996 Dec 1;131(11):457-62, 536. Hebrew.

PMID:
9043151
21.

Increased manganese-superoxide dismutase activity in postmortem brain from neuroleptic-treated psychotic patients.

Loven DP, James JF, Biggs L, Little KY.

Biol Psychiatry. 1996 Aug 1;40(3):230-2. No abstract available.

PMID:
8830959
22.

Hodgkin disease in children: reduced tailored chemotherapy for stage I-II disease.

Yaniv I, Saab A, Cohen IJ, Goshen Y, Loven D, Stark B, Tamary H, Zaizov R.

J Pediatr Hematol Oncol. 1996 Feb;18(1):76-80.

PMID:
8556376
23.

Multiple basal cell carcinomas of the leg after recurrent erysipelas and chronic lymphedema.

Lotem M, Tamir G, Loven D, David M, Hauben D.

J Am Acad Dermatol. 1994 Nov;31(5 Pt 1):812-3. No abstract available.

PMID:
7929934
24.

Hormone receptors in initially excised versus recurrent intracranial meningiomas.

Rubinstein AB, Loven D, Geier A, Reichenthal E, Gadoth N.

J Neurosurg. 1994 Aug;81(2):184-7.

PMID:
8027799
25.

An evaluation of lateral and medial transposition of the ovaries out of radiation fields.

Hadar H, Loven D, Herskovitz P, Bairey O, Yagoda A, Levavi H.

Cancer. 1994 Jul 15;74(2):774-9.

PMID:
8033059
26.

The effect of irradiation on expression of HLA class I antigens in human brain tumors in culture.

Klein B, Loven D, Lurie H, Rakowsky E, Nyska A, Levin I, Klein T.

J Neurosurg. 1994 Jun;80(6):1074-7.

PMID:
8189262
27.

An unusual presentation of adenoid cystic carcinoma of the lacrimal gland.

Levartovsky S, Milstein A, Nissim F, Loven D, Shani A.

Ophthalmic Plast Reconstr Surg. 1993;9(1):47-50.

PMID:
8382940
28.

Hemispheric supratentorial low-grade astrocytoma.

Reichenthal E, Feldman Z, Cohen ML, Loven D, Zucker G.

Neurochirurgia (Stuttg). 1992 Jan;35(1):18-22.

PMID:
1570044
29.
30.

Esophageal obstruction 14 years after treatment for Hodgkin's disease.

Kaplinsky C, Kornreich L, Tiomny E, Cohen IJ, Loven D, Zaizov R.

Cancer. 1991 Aug 15;68(4):903-5.

PMID:
1855189
31.

Soluble histocompatibility antigen class I in breast cancer patients in relation to tumor burden.

Klein B, Klein T, Figer A, Bleiberg M, Shapira J, Loven D, Livni E, Lurie H, Niska A.

Cancer. 1991 May 1;67(9):2295-9.

PMID:
2013037
32.

Dactinomycin potentiation of radiation pneumonitis: a forgotten interaction.

Cohen IJ, Loven D, Schoenfeld T, Sandbank J, Kaplinsky C, Yaniv Y, Jaber L, Zaizov R.

Pediatr Hematol Oncol. 1991 Apr-Jun;8(2):187-92. Review.

PMID:
1863544
33.

Marrow antioxidant enzyme activity in tumor-bearing and non-tumor-bearing mice following vincristine treatment.

Johnke RM, Loven DP, Abernathy RS, Bennett MJ, Murphy SA.

Int J Radiat Oncol Biol Phys. 1991 Feb;20(2):369-72.

PMID:
1991702
34.

Immunologic impairment after long-term remission in splenectomized patients with Hodgkin's disease.

Loven D, Pick AI, Weiss H, Duczyminer-Kahana M, Lurie H.

Acta Oncol. 1991;30(6):763-5. No abstract available.

PMID:
1958399
35.

A clinical evaluation of nuclear estrogen receptors combined with cytosolic estrogen and progesterone receptors in breast cancer.

Loven D, Rakowsky E, Geier A, Lunenfeld B, Rubinstein A, Klein B, Lurie H.

Cancer. 1990 Jul 15;66(2):341-6.

PMID:
2369715
36.

A solitary conjunctival relapse of Hodgkin's disease treated by radiotherapy.

Kremer I, Loven D, Mor C, Lurie H.

Ophthalmic Surg. 1989 Jul;20(7):494-6.

PMID:
2779954
37.
38.
39.

Active specific immunotherapy of renal cell carcinoma patients: a prospective randomized study of hormono-immuno-versus hormonotherapy. Preliminary report of immunological and clinical aspects.

Adler A, Gillon G, Lurie H, Shaham J, Loven D, Shachter Y, Shani A, Servadio C, Stein JA.

J Biol Response Mod. 1987 Dec;6(6):610-24.

PMID:
3330126
40.

Effect of insulin and oral glutathione on glutathione levels and superoxide dismutase activities in organs of rats with streptozocin-induced diabetes.

Loven D, Schedl H, Wilson H, Daabees TT, Stegink LD, Diekus M, Oberley L.

Diabetes. 1986 May;35(5):503-7.

PMID:
3514329
41.

Enhanced effect of systemic cyclophosphamide by local tumor hyperthermia in mice.

Loven D, Lurie H, Hazan G.

Cancer Treat Rep. 1986 Apr;70(4):509-12.

PMID:
3698044
42.

Adaptation of the duodenum and ileum of the rat to mid-gut resection: enzyme activity and trace metal status.

Wilson HD, Miller T, Ogesen B, Schedl HP, Failla ML, Loven DP.

Am J Clin Nutr. 1986 Feb;43(2):185-93.

PMID:
3080864
44.

Transformation affects superoxide dismutase activity.

Loven DP, Guernsey DL, Oberley LW.

Int J Cancer. 1984 Jun 15;33(6):783-6.

PMID:
6329968
45.

Lowered superoxide dismutase activity in distant organs of tumor-bearing mice.

Leuthauser SW, Oberley LW, Oberley TD, Loven DP.

J Natl Cancer Inst. 1984 May;72(5):1065-74.

PMID:
6585584
46.

Superoxide dismutase activity in the intestine of the streptozotocin-diabetic rat.

Loven DP, Schedl HP, Oberley LW, Wilson HD, Bruch L, Niehaus CL.

Endocrinology. 1982 Sep;111(3):737-42.

PMID:
7049672
47.
48.

Hormonal receptors and response to treatment of breast cancer: a retrospective evaluation in 60 patients.

Loven D, Rakowsky E, Stein JA, Geier A, Lunenfeld B.

Isr J Med Sci. 1981 Sep-Oct;17(9-10):960-4.

PMID:
7309485
49.

Effect of two intestinal resections separated by time on cell proliferation in the rat small intestine.

Wathen LM, Osborne JW, Loven DP.

Gastroenterology. 1981 Jun;80(6):1535-41. No abstract available.

PMID:
6262183

Supplemental Content

Support Center